QYresearchReports.com
- New Industry Research Report Added in QYresearchreports.com Database Global and China Synthesis
Polypeptide Drug Industry 2012 Deep Research Report
2012 Deep Research
Report on Global and China Synthesis Polypeptide Drug Industry was professional
and depth research report on China Synthesis Polypeptide Drug industry.
To Browse Full Toc Visit: http://www.qyresearchreports.com/report/global-and-china-synthesis-polypeptide-drug-industry-2012-deep-research-report.htm
The report firstly introduced Synthesis Polypeptide Drug
basic information included Synthesis Polypeptide Drug definition classification
application industry chain structure industry overview; international market
analysis, China domestic market analysis, Macroeconomic environment and
economic situation analysis and influence, Synthesis Polypeptide Drug industry
policy and plan, Synthesis Polypeptide Drug product specification,
manufacturing process, product cost structure etc.
then statistics China key manufacturers Synthesis
Polypeptide Drug capacity production cost price profit production value gross
margin etc details information, at the same time, statistics these
manufacturers Synthesis Polypeptide Drug products customers application
capacity market position company contact information etc company related
information, then collect all these manufacturers data and listed China
Synthesis Polypeptide Drug capacity production capacity market share production
market share supply demand shortage import export consumption etc data
statistics, and then introduced China Synthesis Polypeptide Drug 2009-2013
capacity production price cost profit production value gross margin etc
information.
And also listed Synthesis Polypeptide Drug upstream raw
materials equipments and Sharp Solarnstream clients alternative products survey
analysis and Synthesis Polypeptide Drug marketing channels industry development
trend and proposals. In the end, this report introduced Synthesis Polypeptide
Drug new project SWOT analysis Investment feasibility analysis investment
return analysis and also give related research conclusions and development
trend analysis of China Synthesis Polypeptide Drug industry.
In a word, it was a depth research report on China Synthesis
Polypeptide Drug industry. And thanks to the support and assistance from
Synthesis Polypeptide Drug industry chain related technical experts and
marketing engineers during Research Team survey and interviews.
Latest Reports by Qyresearch
Table of Contents
Chapter One Synthesis Polypeptide
Drug Industry Overview 1
1.1 Synthesis Polypeptide Drug
Definition 1
1.2 Synthesis Polypeptide Drug
Classification and Application 3
1.3 Professional Terms
Interpretation 8
1.4 Synthesis Polypeptide Drug
Industry Chain Structure 12
1.5 Synthesis Polypeptide Drug
Industry Overview 14
Chapter Two Synthesis Polypeptide
Drug International and China Market Analysis 16
2.1 Synthesis Polypeptide Drug
Industry International Market Analysis 16
2.1.1 Synthesis Polypeptide Drug
International Market Development History 16
2.1.2 Synthesis Polypeptide Drug
Product and Technology Developments 18
2.1.3 Synthesis Polypeptide Drug
Competitive Landscape Analysis 25
2.1.4 Synthesis Polypeptide Drug
International Key Countries Development Status 28
2.1.5 Synthesis Polypeptide Drug
International Market Development Trend 30
2.2 Synthesis Polypeptide Drug China
Market Analysis 33
2.2.1 Synthesis Polypeptide Drug
China Market Development History 33
2.2.2 Synthesis Polypeptide Drug
Product and Technology Developments 33
2.2.3 Synthesis Polypeptide Drug
Competitive Landscape Analysis 35
2.2.4 Synthesis Polypeptide Drug
China Key Regions Development Status 37
2.2.5 Synthesis Polypeptide Drug
China Market Development Trend 37
2.3 Synthesis Polypeptide Drug
International and China Market Comparison Analysis 42
Chapter Three Major Synthesis
Polypeptide Drug Analysis 43
3.1 Immunity Regulating Medicine
(Allergy Infection and Immune) 43
3.1.1 Glatiramer Injection
(Glatiramer Acetate) 43
3.1.2 Thymalfasin for Injection 46
3.1.3 Thymopentin Injection 49
3.1.4 Thymopetidum Injection 53
3.1.5 Summary 55
3.2 Digestive System Drugs
(Gastrointestinal Type) 57
3.2.1 Octreotide Acetate Injection
57
3.2.2 Somatostatin for Injection 61
3.3 Bone and Connective Tissue Types
(Thyroid hormones Drug) 66
3.3.1 Salmon Calcitonin Injection 67
3.3.2 Elcatonin Injection 70
3.3.4 TerfparaLide Injectlon 72
3.4 Gynecologic or Obstetric Drug 76
3.4.1 Oxytocin Injection 76
3.4.2 Carbetocin Injection 81
3.4.3 Acetate Atosiban Injection 83
3.5 Tumor Drug (hCG) 86
3.5.1 Leuprorelin Acetate
Microspheres for Injection 87
3.5.2 Goserelin Acetate 89
3.5.3 Triptorelin Acetate Injection
92
3.5.4 Chorionic Gonadotrophin for
Injection 95
3.6 Urinary System Drug (Diabetes
Insipidus) 98
3.6.1 Desmopressin Acetate Injection
98
3.6.2 Terlipressin for Injection 101
3.7 Metabolic Drug (Insulin and
Other Hypoglycemic Agents) 105
3.7.1 Biosynthetic Glucagon for
Injection 105
3.7.2 Exenatide Injection 106
Chapter Four Synthesis Polypeptide
Drug Development Environmental Analysis 109
4.1 China's Macroeconomic Environment
Analysis 109
4.1.1 China GDP Analysis 109
4.1.2 China CPI Analysis 111
4.2 European Economic Environmental
Analysis and Impact 113
4.3 United States Economic
Environmental Analysis and Impact 116
4.4 Japan Economic Environmental
Analysis and Impact 119
4.5 Global Economic Environmental
Analysis and Impact 120
4.5.1 Global Economic Environmental
Analysis 120
4.5.2 Global Economic Influence 121
Chapter Five Synthesis Polypeptide
Drug Development Policy and Plan 121
5.1 China Government Policy and
Development Plan 121
5.2 Industry Policy and Standard 122
5.3 Technical Standard 125
5.4 Technology Replacement and
R&D Trends 126
5.5 Hotspots and Influence 127
Chapter Six Synthesis Polypeptide
Drug Manufacturing Process and Cost Structure 132
6.1 Synthesis Polypeptide Drug
Manufacturing Process Overview 132
6.2 Synthesis Polypeptide Drug
Manufacturing Process Analysis 135
6.3 Synthesis Polypeptide Drug Cost
Structure Analysis 138
Chapter Seven 2009-2013 Synthesis
Polypeptide Drug Productions Supply Sales Demand Market Status and Forecast 140
7.1 2009-2013 Synthesis Polypeptide
Drug Capacity Production Overview 140
7.1.1 2009-2013 Global and China
Synthesis Polypeptide Drug Capacity Production 140
7.1.2 2009-2013 Synthesis
Polypeptide Drug Production Market Share 146
7.1.3 2009-2013 Synthesis
Polypeptide Drug Demand Overview 152
7.1.4 2009-2013 Synthesis
Polypeptide Drug Supply Demand and Shortage 152
7.1.5 2009-2013 Synthesis
Polypeptide Drug Production Import Export Consumption 153
7.1.6 2009-2013 Synthesis
Polypeptide Drug Cost Price Production Value Gross Margin 154
7.2 Different Type Synthesis
Polypeptide Drug Sales and Market Scale Analysis 156
7.2.1Thymopentin Injection 156
7.2.2 Thymalfasin Injection 158
7.2.3 Calcitonin Injection 159
7.2.4 Somatostatin for Injection 161
7.2.5Octreotide Acetate Injection
162
7.2.6 Desmopressin Acetate Injection
163
7.3 Synthesis Polypeptide Drug
Market Summary 165
Chapter Eight Synthesis Polypeptide
Drug Key Manufacturers 170
8.1 Novartis 170
8.2 Merck Serono 176
8.3 Ferring Pharmaceuticals 181
8.4 Ipsen PHarma Biotech 188
8.5 Lilly 191
8.6Asahi Kasei 195
8.7 AstraZeneca 199
8.8 SciClone Pharmaceuticals 203
8.9 Takeda 206
8.10 HYBIO Pharmaceutical Co.,Ltd
(Shenzhen Stock:300199) 210
8.11 Hainan Zhonghe Pharmaceutical
Co.,Ltd 215
8.12 Sichuan Chengdu Diao
Pharmaceutical Group Co.,Ltd 219
8.13 Beijing Yingu Century
Pharmaceutical Co.,Ltd (Beijing Shiqiao Bio-Pharmaceutical Co.,Ltd) 224
8.14 Hainan Shuangcheng
Pharmaceuticals Co.,Ltd 227
8.15 Livzon Pharmaceuticals Co.,Ltd
(Livzon:000513) 234
8.16 Wuhan Hualong Bio-Chemical
Pharmaceutical Co.,Ltd 238
8.17 Chengdu Tiantaishan
Pharmaceutical Co.,Ltd 242
8.18 Beijing Shuanglu Pharmaceutical
Co.,Ltd 250
8.19 Yangzijiang Pharmaceutical
Co.,Ltd 257
8.20 Changzhou Siyao Pharmaceutical
Co.,Ltd 262
Chapter Nine Up and Down Stream
Industry Analysis and Influence 267
9.1 Upstream Raw Materials Price
Analysis and Influence 267
9.1 Upstream Equipments Market
Analysis and Influence 269
9.3 Downstream Demand Analysis and
Influence 270
9.4 Industry Policy Analysis and
Influence 271
Chapter Ten Synthesis Polypeptide
Drug Marketing Channels Analysis 272
10.1 Synthesis Polypeptide Drug
Marketing Channels Status 272
10.1.1 Drugs Marketing Channel
Developemnt History 272
10.1.1 Prescription Drug Marketing
Development Status 273
10.2 Synthesis Polypeptide Drug
Marketing Channels Management 274
10.3 Synthesis Polypeptide Drug
Marketing Channels Establishment 275
10.4 Synthesis Polypeptide Drug
Marketing Channels Development Trend 276
Chapter Eleven Synthesis Polypeptide
Drug Industry Development Trend 278
11.1 2012-2016 Synthesis Polypeptide
Drug Industry Development Trend 278
11.2 2012-2016 Market Potential Forecast
279
11.3 2012-2016 R&D Trend 280
11.3.1Polypeptide Drug Technical
Development Status 280
11.3.2 Polypeptide Drug and Health
Care Products Research and Manufacturing Overview 282
11.3.3 China Polypeptide Drug
Development Direction and Prospect 283
11.4 2012-2016 Marketing Channels
Change Trend 285
11.4.1 Prescription Drug Marketing
Channels Change Trend 285
11.4.2 Prescription Drug Sales
Method Five Trend 286
11.5 2012-2016 Competition Pattern
Development Trends 288
Chapter Twelve Synthesis Polypeptide
Drug Industry Development Proposals 289
12.1 Macroeconomic Development
Countermeasures 289
12.2 New Firms Enter Market Strategy
290
12.2.1 New Business Entry Barriers
290
12.2.2 New Corporate Strategy 290
12.3 New Project Investment Proposal
293
12.4 Marketing Channel Strategy
Proposals 294
12.5 Competitive Environment
Strategy Proposals 296
12.5.1 Competitive Environment
Analysis 296
12.5.2 Strategy Proposals 297
Chapter Thirteen Synthesis
Polypeptide Drug New Project Investment Feasibility Analysis 300
13.1 Synthesis Polypeptide Drug
Project SWOT Analysis 300
13.2 Synthesis Polypeptide Drug New
Project Investment Feasibility Analysis 302
13.2.1 Buildings 302
13.2.2 Investment 303
13.2.3 Project Schedule 303
13.2.4 Project Investment Return and
Feasibility Analysis 304
Chapter Fourteen Synthesis
Polypeptide Drug Industry Research Conclusions 304
Latest Reports by Qyresearch
List of Figures
Figure Synthesis Polypeptide Process
Flow 1
Figure Synthesis Polypeptide Drug
Picture-Thymopentin Injection 2
Figure Polypeptide Applications on
Health Care Food and Cosmetics Fields 4
Figure Polypeptide Drug
Manufacturing Process Method 4
Table Synthesis Polypeptide Drug
Classification and Application List 5
Table Synthesis Polypeptide Drug
Product Name Use and Annual Sales Revenue (USD) List 6
Table Listed Polypeptide Drug Name
Type Indication 6
Figure Pharmaceutical Industry Value
Chain Structure 12
Figure Pharmaceutical Industry
Industry Chain Structure 12
Figure Synthesis Polypeptide Drug
Industry Chain Structure 13
Figure Synthesis Polypeptide Drug
Industrialization System 13
Figure 2000-2011 China
Pharmaceutical Industry Sales Revenue and Total Profit (100 Million RMB) and
Growth Rate 14
Figure 2007-2015 China Synthesis
Polypeptide Drug Market Scale (100 Million RMB) and Growth Rate 15
Figure DNA Transcribed into RNA
Diagram 17
Figure RNA Translated into
Polypeptide Chains Molecular Diagram 18
Table Polypeptide Drug Three
Manufacturing Methods 19
Figure 1984 Chemistry Nobel Prize
Winner Robert Bruce Merrifield 20
Figure Polypeptide Solid Phase
Synthesis Principle 20
Figure Solid Phase Polypeptide
Synthesis 21
Figure United States CS Three
Channel Full Automatic Polypeptide Synthetic Instrument 22
Figure Homemade CS136 Model Research
Polypeptide Synthetic Instrument 23
Figure Large Scale Liquid Phase
Synthesis of Polypeptide 24
Figure Thin Film Evaporator (for
perishable goods Concentration) 24
Table Global 2008 Revenue More than
1 Billion Polypeptide Drug Brands List 25
Table Some Listed Polypeptide Drug
Indication Classification 26
Figure Listed Polypeptide Drug
Indication Classification Market Share 26
Figure 2004-2014 Global
Pharmaceutical Sales Revenue (Billion USD) and Growth Rate 30
Figure 2009-2013 International
Synthesis Polypeptide Drug Market Scale (100 Million RMB) and Growth Rate 31
Table 2011 Some Polypeptide Drug
Global Sales Revenue (100 Million USD) 31
Figure Each Year Enter Clinical
Research Polypeptide Drug Quantity (Piece) 32
Table 17 Emerging Pharmaceutical
Market Sizes (Billion USD) 38
Figure 2007-2015 China
Pharmaceutical Sales Revenue (100 Million USD) 39
Figure 2009-2015 China Polypeptide
Drug Market Scale (100 Million RMB) and Growth Rate 39
Figure 2009-2015 China Chemical
Synthesis Polypeptide Drug Market Scale (100 Million RMB) and Growth Rate 40
Figure 2009-2015 China Chemical
Synthesis Polypeptide Drug Market Scale (100 Million RMB) and Proportion of
China Total Polypeptide Drug Market Scale 41
Figure 2007-2009 China Chemical
Synthesis Polypeptide Drug Types Market Share 41
Table Copaxone Neuron Structure
Diagram 44
Table Thymalfasin for Injection
(Thymalfasin a1) Suppliers List 48
Table 2010 Thymalfasin for Injection
Key Products Price (RMB/Piece) List 49
Table Some Thymopentin Injection
Suppliers List 51
Table Thymopentin Injection Hospital
Purchase Price (RMB/Piece) List 52
Table Thymopetidum Injection
Thymopentin Injection Thymalfasin Injection Comparison 56
Table Octreotide Acetate Injection
Key Suppliers List 59
Table 2012 Hebei Province Octreotide
Acetate Injection Bid Price List 60
Tale Somatostatin for Injection Key
Suppliers List 64
Table Somatostatin for Injection Key
Products Hospital Average Purchae Price List 64
Table 2012 Hebei Province
Somatostatin for Injection Key Suppliers List 65
Table Salmon Calcitonin Injection Suppliers
List 69
Table Salmon Calcitonin
Injection/Nasal Spray Products Hospital Purchase Price List 69
Table Salmon Calcitonin
Injection/Nasal spray Products Retail Price List 70
Table Elcatonin Injection Key
Suppliers and Product Selling Price List 72
Figure TerfparaLide
Injectlon—Forsteo Injection Pen Parts 75
Table 2011Q1 China Some Aproved New
Drug Number, Specifications Suppliers and Indication 76
Table 2012 New Add Key Monitoring
Drug Table--TerfparaLide Injectlon 76
Table Oxytocin Injection Key Suppliers
List 78
Table Oxytocin Injection Suppliers
Products Models List 80
Table Carbetocin Injection Suppliers
List 83
Table Acetate Atosiban Injection
Supplier Product Specification Price List 85
Table Leuprorelin Acetate
Microspheres for Injection Suppliers Product Specification Price List 88
Table Triptorelin Acetate Injection
Suppliers Product Specification Price List 94
Table Chorionic Gonadotrophin for
Injection Suppliers Product Specifications List 97
Table 2011 Some Hormone Drugs
Independent Pricing and Uniform Pricing Comparison 98
Table Desmopressin Acetate Injection
Key Suppliers List 100
Table Desmopressin Acetate Injection
Key Suppliers Forms Product Specifications and Bid Price List 101
Table Terlipressin for Injection Key
Brands Manufacturers and Retail Prices 104
Table Biosynthetic Glucagon for
Injection Suppliers and Retail Prices List 106
Table Exenatide Suppliers Product
Specifications Retail Prices List 109
Figure 2007-2015 China Medical Industry
Total Production Value (100 Million RMB) and Growth Rate 110
Table 2006-2011 China GDP (1000
Million RMB) and Growth Rate 110
Figure 2007-2011 China Medical
Industry Total Value and Its Proportion of China Total GDP 111
Figure 2007-2015 China Individual
Medical Expenditure (RMB) 112
Figure 2007-2015 China Health
Expenditure Per Capita and National Medical Expenditure Comparison 112
Figure 2011-2016 China Population
Growth and Aging Condition 113
Figure 2006-2011 Europe Several
Countries PMI Trend 114
Figure United States CPI and PCE
Growth Comparison 117
Figure United States Private Savings
Rate Change and Net Export /GDP Proportion Change Trend 118
Figure United States Public Debt and
Deficit Proportion of GDP 119
Figure Japan GDP and CPI Growth Rate
Comparison 119
Figure 2009-2011 China Health
Capital Investment (100 Million RMB) 122
Table China Pharmaceutical Industry
All major Departments and Regulatory Functions 122
Table Pharmaceutical Industry main
Laws and Regulations and Policies 125
Table 2009-2012 China Medical and
Health System Reform Important Policy 128
Table 2009-2012 China Related
Pharmaceutical Product Quality Supervision Policy 129
Table 2008-2012 China Development
and Reform Commission Policy on Drug Price Management Policies 130
Figure PTIPolypeptide Synthetic
Instruments Picture 133
Table Synthesis Polypeptide Drug
Technology Processes List 133
Figure Polypeptide Pharmaceutical
Raw Materials Manufacturing Process Flow 135
Figure Freeze Dried Powder Injection
Manufacturing Process Flow 136
Figure Small Capacity Injection
Manufacturing Process Flow 136
Figure Thymalfasin API Manufacturing
Process Flow 137
Figure Thymalfasin Injection
Manufacturing Process Flow 138
Figure International Synthesis
Polypeptide Drug Cost Structure 139
Table 2009-2011 China Synthesis
Polypeptide Drug Cost Structure 139
Table 2009-2013 Global Key
Manufacturers Synthesis Polypeptide Drug Capacity and Total Capacity (10K
Piece) List 140
Table 2009-2013 Global Key
Manufacturers Synthesis Polypeptide Drug Capacity Market Share List 140
Table 2009-2013 Global Key
Manufacturers Synthesis Polypeptide Drug Production and Total Production (10K
Piece) List 141
Table 2009-2013 Global Key
Manufacturers Synthesis Polypeptide Drug Production Market Share List 141
Table 2009-2013 China Key
Manufacturers Synthesis Polypeptide Drug Capacity and Total Capacity (10K
Piece) List 142
Table 2009-2013 China Key
Manufacturers Synthesis Polypeptide Drug Capacity Market Share List 142
Table 2009-2013 China Key
Manufacturers Synthesis Polypeptide Drug Production and Total Production (10K
Piece) List 143
Table 2009-2013 China Key
Manufacturers Synthesis Polypeptide Drug Production Market Share List 143
Figure 2009-2013 Global Synthesis
Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 144
Table 2009-2013 Global Synthesis
Polypeptide Drug Capacity Utilization Rate List 144
Figure 2009-2013 China Synthesis
Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 145
Table 2009-2013 China Synthesis
Polypeptide Drug Capacity Utilization Rate List 145
Table 2009-2013 Key Manufacturers
Synthesis Polypeptide Drug China Sales (10K Piece) Top20 List 146
Table 2009-2013 Key Manufacturers
Synthesis Polypeptide Drug China Sales Top20 Market Share List 147
Table 2010 Key Manufacturers
Synthesis Polypeptide Drug China Sales Revenue (100 Million RMB) Top10 List 147
Table 2008-2010 Key Manufacturers
Synthesis Polypeptide Drug China Sales Revenue Top10 Market Share List 148
Figure 2011 Key Manufacturers
Synthesis Polypeptide Drug China Sales Market Share 149
Figure 2012 Key Manufacturers
Synthesis Polypeptide Drug China Sales TOP20 Market Share 150
Figure 2011 China Key Manufacturers
Synthesis Polypeptide Drug Production Market Share 151
Figure 2012 China Key Manufacturers
Synthesis Polypeptide Drug Production Market Share 151
Table 2009-2013 Global Synthesis
Polypeptide Drug Demand (10K Piece) and Growth Rate 152
Table 2009-2013 China Synthesis
Polypeptide Drug Demand (10K Piece) and Growth Rate 152
Table 2009-2013 China Synthesis Polypeptide
Drug Supply Demand and Shortage (10K Piece) 153
Table 2009-2013 Nine Foreign
Enterprises Synthesis Polypeptide Drug China Sales (10K Piece) List 153
Table 2009-2013 China Synthesis
Polypeptide Drug Production Import Export Consumption (10K Piece) List 154
Table 2007-2009 China Synthesis
Polypeptide Drug Price (RMB/Piece) Distribution 154
Table 2009-2011 Hainan Shuangcheng
Pharmaceuticals Some Synthesis Polypeptide Drug Price Cost (RMB/Piece) Gross
Margin List 155
Table 2009-2013 China Synthesis
Polypeptide DrugProduction (10K Piece) Price Cost Gross (RMB/Piece) Production
Value (10K RMB) Gross Margin List 155
Figure 2011 China Synthesis
Polypeptide Drug Market Share by Different Type Drug 156
Figure 2008-2014 China Thymopentin
Injection Market Scale (100 Million RMB) and Growth Rate 157
Figure 2008-2014 China Thymopentin
Injection Sales (10K Piece) and Growth Rate 157
Figure 2008-2014 China Thymalfasin Injection
Market Scale (100 Million RMB) and Growth Rate 158
Figure 2008-2014 China Thymalfasin
Injection Sales (10K Piece) and Growth Rate 159
Figure 2008-2014 China Calcitonin
Injection Market Scale (100 Million RMB) and Growth Rate 160
Figure 2008-2014 China Calcitonin
Injection Sales (10K Piece) and Growth Rate 160
Figure 2008-2014 China Somatostatin
for Injection Market Scale (100 Million RMB) and Growth Rate 161
Figure 2008-2014 China Somatostatin
for Injection Sales (10K Piece) and Growth Rate 162
Figure 2008-2014 China Octreotide
Acetate Injection Market Scale (100 Million RMB) and Growth Rate 163
Figure 2008-2014 China Octreotide
Acetate Injection Sales (10K Piece) and Growth Rate 163
Figure 2008-2014 China Desmopressin
Acetate Injection Market Scale (100 Million RMB) and Growth Rate 164
Figure 2008-2014 China Desmopressin
Acetate Injection Sales (10K Piece) and Growth Rate 164
Table 2009-2011 China Chemical
Synthesis Polypeptide Drug Injection Distribution List 165
Figure 2010 Global Polypeptide Drug
Market Structure by Treatment Class 165
Table Research or Listed Polypeptide
Drugs List 166
Figure 1990-2010 China Resident
Three Types of Chronic Disease Prevalence (1/100K) Change Trend 167
Figure 2010 China Synthesis
Polypeptide Drug Hospital Terminal Sales Market Share Distribution 168
Figure 2010 China Synthesis
Polypeptide Drug Top10 Manufacturers Sales Revenue (100 Million RMB) 168
Figure China Synthesis Polypeptide
Drug Prices Distribution 169
Figure Use Me-Too Model Developed
Polypeptide Drug List 169
Table Novartis Company Information
Table (Products Applications Manufacturing Base Location Capacity Expansion
Plan Market Position Contact Information etc 13 Items) 170
Figure Novartis China Market Sales
Synthesis Polypeptide Drug--Octreotide Acetate Injection 173
Figure Novartis China Market Sales
Synthesis Polypeptide Drug--Somatostatin Acetate for Injection 173
Figure Novartis China Market Sales
Synthesis Polypeptide Drug--salmon Calcitonin Nasal Spray 174
Table 2009-2013 Novartis Synthesis
Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production
Value (10K RMB) Gross Margin List 174
Figure 2009-2013 Novartis Synthesis
Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 175
Table Merck Serono Company
Information Table (Products Applications Manufacturing Base Location Capacity
Expansion Plan Market Position Contact Information etc 13 Items) 176
Figure Merck Serono Synthesis
Polypeptide Drug--Recombinant Human Follitropin Alfa Solution for Injection 178
Figure Merck Serono Synthesis
Polypeptide Drug--Somatostatin for Injection 179
Figure Merck Serono Synthesis
Polypeptide Drug--Gonadorelin for Injection 179
Table 2009-2013 Merck Serono
Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece)
Production Value (10K RMB) Gross Margin List 180
Figure 2009-2013 Merck Serono
Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 181
Table Ferring Pharmaceuticals
Company Information Table (Products Applications Manufacturing Base Location
Capacity Expansion Plan Market Position Contact Information etc 13 Items) 182
Figure Ferring Pharmaceuticals China
Market Sales Synthesis Polypeptide Drug--Minirin 183
Figure Ferring Pharmaceuticals China
Market Sales Synthesis Polypeptide Drug--Decapeptyl 184
Figure Ferring Pharmaceuticals China
Market Sales Synthesis Polypeptide Drug--Pentasa 184
Figure Ferring Pharmaceuticals China
Market Sales Synthesis Polypeptide Drug--Glypressin 185
Figure Ferring Pharmaceuticals China
Market Sales Synthesis Polypeptide Drug--Octostim 186
Table 2009-2013 Ferring
Pharmaceuticals Synthesis Polypeptide Drug Production (10K Piece) Cost Price
Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 186
Figure 2009-2013 Ferring
Pharmaceuticals Synthesis Polypeptide Drug Capacity Production (10K Piece) and
Growth Rate 188
Table Ipsen PHarma Biotech Company
Information Table (Products Applications Manufacturing Base Location Capacity
Expansion Plan Market Position Contact Information etc 13 Items) 188
Figure Ipsen PHarma Biotech
Synthesis Polypeptide Drug--Triptorelin Acetate for Injection 190
Table 2009-2013 Ipsen PHarma Biotech
Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece)
Production Value (10K RMB) Gross Margin List 190
Figure 2009-2013 Ipsen PHarma
Biotech Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth
Rate 191
Table Lilly Company Information
Table (Products Applications Manufacturing Base Location Capacity Expansion
Plan Market Position Contact Information etc 13 Items) 192
Figure Lilly Some China Listed
Synthesis Polypeptide Drug List 194
Table 2009-2013 Lilly Synthesis
Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production
Value (10K RMB) Gross Margin List 194
Figure 2009-2013 Lilly Synthesis
Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 195
Table Asahi Kasei Company
Information Table (Products Applications Manufacturing Base Location Capacity
Expansion Plan Market Position Contact Information etc 13 Items) 195
Figure Asahi Kasei Synthesis
Polypeptide Drug--Elcatonin Injection 198
Table 2009-2013 Asahi Kasei
Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece)
Production Value (10K RMB) Gross Margin List 198
Figure 2009-2013 Asahi Kasei
Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 199
Table AstraZeneca Company
Information Table (Products Applications Manufacturing Base Location Capacity
Expansion Plan Market Position Contact Information etc 13 Items) 199
Figure AstraZeneca China Selling
Synthesis Polypeptide Drug—Goserelin Acetate Slow Release Implantation Agent
201
Table 2009-2013 Jiangsu AstraZeneca
Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece)
Production Value (10K RMB) Gross Margin List 202
Figure 2009-2013 Jiangsu AstraZeneca
Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 203
Table SciClone Pharmaceuticals
Company Information Table (Products Applications Manufacturing Base Location
Capacity Expansion Plan Market Position Contact Information etc 13 Items) 204
Figure SciClone Pharmaceuticals
Synthesis Polypeptide Drug-- Thymopetidum α１ Injection 205
Table 2009-2013 SciClone
Pharmaceuticals Synthesis Polypeptide Drug Production (10K Piece) Cost Price
Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 205
Figure 2009-2013 SciClone
Pharmaceuticals Synthesis Polypeptide Drug Capacity Production (10K Piece) and Growth
Rate 206
Table Takeda Company Information
Table (Products Applications Manufacturing Base Location Capacity Expansion
Plan Market Position Contact Information etc 13 Items) 206
Figure Takeda--Leuprorelin Acetate
Microspheres for Injection 208
Table 2009-2013 Takeda Synthesis
Polypeptide Drug Production (10K Piece) Cost Price Gross (RMB/Piece) Production
Value (10K RMB) Gross Margin List 209
Figure 2009-2013 Takeda Synthesis
Polypeptide Drug Capacity Production (10K Piece) and Growth Rate 209
Table HYBIO Pharmaceutical Co.,Ltd
Company Information Table (Products Applications Manufacturing Base Location
Capacity Expansion Plan Market Position Contact Information etc 13 Items) 210
Figure 2009-2013 HYBIO
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug 211
Table 2009-2013 HYBIO Pharmaceutical
Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross
(RMB/Piece) Production Value (10K RMB) Gross Margin List 213
Figure 2009-2013 HYBIO
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K
Piece) and Growth Rate 215
Table Hainan Zhonghe Pharmaceutical
Co.,Ltd Company Information Table (Products Applications Manufacturing Base
Location Capacity Expansion Plan Market Position Contact Information etc 13
Items) 216
Figure Hainan Zhonghe Pharmaceutical
Co.,Ltd Synthesis Polypeptide Drug产品 217
Table 2009-2013 Hainan Zhonghe
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost
Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 217
Figure 2009-2013 Hainan Zhonghe
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K
Piece) and Growth Rate 219
Table Sichuan Chengdu Diao
Pharmaceutical Group Co.,Ltd Company Information Table (Products Applications
Manufacturing Base Location Capacity Expansion Plan Market Position Contact
Information etc 13 Items) 219
Figure Sichuan Chengdu Diao
Pharmaceutical Group Co.,Ltd Synthesis Polypeptide Drug—Thymalfasin Injection
221
Figure Sichuan Chengdu Diao
Pharmaceutical Group Co.,Ltd Synthesis Polypeptide Drug—Thymopentin Injection
222
Table 2009-2013 Sichuan Chengdu Diao
Pharmaceutical Group Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece)
Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 222
Figure 2009-2013 Sichuan Chengdu
Diao Pharmaceutical Group Co.,Ltd Synthesis Polypeptide Drug Capacity
Production (10K Piece) and Growth Rate 223
Table Beijing Yingu Century
Pharmaceutical Co.,Ltd Company Information Table (Products Applications
Manufacturing Base Location Capacity Expansion Plan Market Position Contact
Information etc 13 Items) 224
Figure Beijing Yingu Century
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Salmon Calcitonin Nasal Spray
225
Figure Beijing Yingu Century
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Thymopentin Injection 226
Table 2009-2013 Beijing Yingu
Century Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K
Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin
List 226
Figure 2009-2013 Beijing Yingu
Century Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production
(10K Piece) and Growth Rate 227
Table Hainan Shuangcheng
Pharmaceuticals Co.,Ltd Company Information Table (Products Applications
Manufacturing Base Location Capacity Expansion Plan Market Position Contact
Information etc 13 Items) 228
Figure Hainan Shuangcheng
Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug--Thymalfasin Injection（基泰） 229
Figure Hainan Shuangcheng
Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug—Somatostatin for Injection
231
Figure Hainan Shuangcheng
Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug—Thymopentin Injection （双成可维） 232
Table 2009-2013 Hainan Shuangcheng
Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost
Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 233
Figure 2009-2013 Hainan Shuangcheng
Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K
Piece) and Growth Rate 234
Table Livzon Pharmaceuticals Co.,Ltd
Company Information Table (Products Applications Manufacturing Base Location
Capacity Expansion Plan Market Position Contact Information etc 13 Items) 234
Figure Livzon Pharmaceuticals
Co.,Ltd Synthesis Polypeptide Drug 236
Table 2009-2013 Livzon Pharmaceuticals
Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost Price Gross
(RMB/Piece) Production Value (10K RMB) Gross Margin List 236
Figure 2009-2013 Livzon
Pharmaceuticals Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K
Piece) and Growth Rate 238
Table Wuhan Hualong Bio-Chemical
Pharmaceutical Co.,Ltd Company Information Table (Products Applications
Manufacturing Base Location Capacity Expansion Plan Market Position Contact
Information etc 13 Items) 239
Figure Wuhan Hualong Bio-Chemical
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug--Thymopentin Injection 240
Figure Wuhan Hualong Bio-Chemical
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug--Somatostatin for Injection
240
Table 2009-2013 Wuhan Hualong
Bio-Chemical Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K
Piece) Cost Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin
List 241
Figure 2009-2013 Wuhan Hualong
Bio-Chemical Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity
Production (10K Piece) and Growth Rate 242
Table Chengdu Tiantaishan
Pharmaceutical Co.,Ltd Company Information Table (Products Applications
Manufacturing Base Location Capacity Expansion Plan Market Position Contact
Information etc 13 Items) 242
Figure Chengdu Tiantaishan Pharmaceutical
Co.,Ltd Synthesis Polypeptide Drug—Somatostatin for Injection 244
Figure Chengdu Tiantaishan
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug—Thymopentin Injection 246
Figure Chengdu Tiantaishan
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug—Octreotide Acetate Injection
247
Table 2009-2013 Chengdu Tiantaishan
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost
Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 248
Figure 2009-2013 Chengdu Tiantaishan
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K
Piece) and Growth Rate 249
Table Beijing Shuanglu
Pharmaceutical Co.,Ltd Company Information Table (Products Applications
Manufacturing Base Location Capacity Expansion Plan Market Position Contact
Information etc 13 Items) 250
Figure Beijing Shuanglu
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Thymopentin Injection 251
Figure Beijing Shuanglu
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug-Salmon Calcitonin Injection
252
Table Beijing Shuanglu
Pharmaceutical Co.,Ltd Thymopentin Injection Price List 253
Table 2009-2013 Beijing Shuanglu
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost
Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 256
Figure 2009-2013 Beijing Shuanglu
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K
Piece) and Growth Rate 257
Table Yangzijiang Pharmaceutical
Co.,Ltd Company Information Table (Products Applications Manufacturing Base
Location Capacity Expansion Plan Market Position Contact Information etc 13
Items) 257
Figure Yangzijiang Pharmaceutical
Co.,Ltd Synthesis Polypeptide Drug-Somatostatin for Injection 259
Figure Yangzijiang Pharmaceutical
Co.,Ltd Synthesis Polypeptide Drug-Thymopentin Injection 260
Table 2009-2013 Yangzijiang
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost
Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 260
Figure 2009-2013 Yangzijiang
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K
Piece) and Growth Rate 261
Table Changzhou Siyao Pharmaceutical
Co.,Ltd Company Information Table (Products Applications Manufacturing Base
Location Capacity Expansion Plan Market Position Contact Information etc 13
Items) 262
Figure Changzhou Siyao
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug List 264
Table Changzhou Siyao Pharmaceutical
Co.,Ltd Chemical Pharmaceutical Raw Materials List 264
Table Changzhou Siyao Pharmaceutical
Co.,Ltd Chemical Raw Materials Intermediates List 265
Table 2009-2013 Changzhou Siyao
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Production (10K Piece) Cost
Price Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 266
Figure 2009-2013 Changzhou Siyao
Pharmaceutical Co.,Ltd Synthesis Polypeptide Drug Capacity Production (10K
Piece) and Growth Rate 266
Table Synthesis Polypeptide Drug
Project Key Equipments and Price (10K RMB) 269
Table Synthesis Polypeptide Drug
Project Equipments List and Price (10K RMB) 270
Table Drugs Manufacturing Enterprise
Specialized Academic Promotion Organization Frame 276
Figure Synthesis Polypeptide Drug
Industry Entry Barriers List 293
Table 2012 China Synthesis Polypeptide
Drug New Project SWOT Analysis 300
Table 2012 China Synthesis
Polypeptide Drug New Project Buildings List 302
Table 2012 China Synthesis
Polypeptide Drug New Project Investments (10K RMB) List 303
Table Synthesis Polypeptide Drug New
Project Investment Return and Feasibility Analysis 304
About Us
QYresearchreports.com focuses on wind and solar energy markets. Apart from
providing market research reports we are also capable of providing customized
services comprising of primary interviews and in-depth market surveys. Our
primary focus is to provide the best in class, in-depth and reliable market
data related to Chinese markets.
Contact
M/s
Sheela
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
No comments:
Post a Comment